Table 2: HAART Regimen Changes at 12 Months by Initial Regimen Class and Period.

Class 1996-2001 2002-2007 2008-2012
% of regimen switched #switched/
#initiated (%)
% of regimen switched #switched/
#initiated (%)
% of regimen switched #switched/
#initiated (%)
NNRTI 11.80% 55/245 (22.45%) 49.45% 45/330 (13.64%) 50.94% 27/262 (10.31%)
Boosted PI 2.58% 12/25 (48.00%) 19.78% 18/80 (22.50%) 35.85% 19/64 (29.69%)
Unboosted PI 78.76% 367/1215 (30.21%) 10.99% 10/24 (41.67%) 7.55% 4/8 (50.00%)
Integrase Inhibitor 0.00% 0/0 0.00% 0/0 3.77% 2/33 (6.06%)
3NRTI 1.29% 6/37 (16.22%) 12.09% 11/30 (36.67%) 0.00% 0/0
Other 5.58% 26/86 (30.23%) 6.59% 6/11 (54.55%) 1.89% 1/4 (20.00%)
Non-HAART 0.00% 0/0 1.10% 1/2 (50.00%) 0.00% 0/1 (0.00%)

Abbreviations: HAART, highly active antiretroviral therapy; NNRTI, non-nucleoside reverse transcriptase inhibitor; PI, protease inhibitor; NRTI, nucleoside reverse transcriptase inhibitor.